Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Blood advances - 7(2023), 14 vom: 25. Juli, Seite 3760-3763 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kalac, Matko [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Azacitidine |
|---|
| Anmerkungen: |
Date Completed 21.07.2023 Date Revised 12.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1182/bloodadvances.2022009445 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352974788 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352974788 | ||
| 003 | DE-627 | ||
| 005 | 20240312233000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2022009445 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1324.xml |
| 035 | |a (DE-627)NLM352974788 | ||
| 035 | |a (NLM)36790924 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kalac, Matko |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.07.2023 | ||
| 500 | |a Date Revised 12.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a romidepsin |2 NLM | |
| 650 | 7 | |a CX3T89XQBK |2 NLM | |
| 650 | 7 | |a Azacitidine |2 NLM | |
| 650 | 7 | |a M801H13NRU |2 NLM | |
| 650 | 7 | |a Depsipeptides |2 NLM | |
| 700 | 1 | |a Jain, Salvia |e verfasserin |4 aut | |
| 700 | 1 | |a Tam, Constantine S |e verfasserin |4 aut | |
| 700 | 1 | |a Xiao, Zhengrui |e verfasserin |4 aut | |
| 700 | 1 | |a Montanari, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Kanakry, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Huber, Bryan D |e verfasserin |4 aut | |
| 700 | 1 | |a Goldfinger, Mendel |e verfasserin |4 aut | |
| 700 | 1 | |a O'Connor, Owen A |e verfasserin |4 aut | |
| 700 | 1 | |a Marchi, Enrica |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d 2016 |g 7(2023), 14 vom: 25. Juli, Seite 3760-3763 |w (DE-627)NLM268683263 |x 2473-9537 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2023 |g number:14 |g day:25 |g month:07 |g pages:3760-3763 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/bloodadvances.2022009445 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2023 |e 14 |b 25 |c 07 |h 3760-3763 | ||